Sam Alworth ^UDM

Sam Alworth is the CEO and co-founder at AcuraStem. With over 20 years of experience in life sciences covering research, drug development, and business development, he actively advances drug candidates for ALS and FTD. Alworth has a technical background in applying artificial intelligence and machine learning to life science assay platforms. He led the implementation of informatics pipelines, incorporating innovative machine learning and traditional image processing algorithms for the iNeuroRx® platform. AcuraStem is pioneering patient-based therapeutics for neurodegenerative diseases.